Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis


Shockwave Javelin IVL catheter shows positive results in pivotal FORWARD CAD study


Petosemtamab combination cuts risk of death by 50% in Phase III head and neck cancer trial


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs)

Presented by Dr Friedrich von Wintzingerode, QC Lead iNeST (individual Neoepitope Specific Therapy), Roche and Nahuel Paolini, PhD, Sanquin Reagents
28th March 2022


Designing production facilities of the future

Presented by Geoffrey Hodge, Chief Technical Officer at Unum Therapeutics and Gary M. Pigeau, Ph.D., Director - Centre for Advanced Therapeutic Cell Technologies at GE Healthcare
30th July 2019


Orthogonal Measures of Lentiviral Particle Attributes Using DLS, NTA, and Micro Flow Cytometry

Presented by Jim Richardson, Senior Director, Analytical Development at Interius Biotherapeutics and Kevin Lance, PhD, Director of Analytics Marketing at Unchained Labs
16th February 2023


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia